• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXHL1800190 PF-06651600片 ritlecitinib Tablet Chemical Drugs(1) Import Drug Application 2018-12-29 辉瑞投资有限公司 Pfizer Investment Co Ltd In Review 2018-12-28 view
JXHL1800189 PF-06651600片 ritlecitinib Tablet Chemical Drugs(1) Import Drug Application 2018-12-29 辉瑞投资有限公司 Pfizer Investment Co Ltd In Review 2018-12-28 view
JYHB1900606 PF-06651600片 ritlecitinib Tablet Chemical Drugs Supplementary Application 2019-05-27 辉瑞投资有限公司 Pfizer Investment Co Ltd Certificate Issued 2019-08-12 view
JYHB1900607 PF-06651600片 ritlecitinib Tablet Chemical Drugs Supplementary Application 2019-05-27 辉瑞投资有限公司 Pfizer Investment Co Ltd Certificate Issued 2019-08-12 view
JXHL1900196 PF-06651600片 ritlecitinib Tablet Chemical Drugs(1) Import Drug Application 2019-08-27 辉瑞投资有限公司 Pfizer Investment Co Ltd In Review 2019-08-26 view
JYHB2000737 PF-06651600片 ritlecitinib Tablet Chemical Drugs Supplementary Application 2020-06-13 辉瑞投资有限公司 Pfizer Investment Co Ltd In Review 2020-06-23 view
JXHB2000021 PF-06651600片 ritlecitinib Tablet Chemical Drugs(1) Supplementary Application 2020-09-03 辉瑞投资有限公司 Pfizer Investment Co Ltd In Review 2020-09-02 view
JXHB2000020 PF-06651600片 ritlecitinib Tablet Chemical Drugs(1) Supplementary Application 2020-09-03 辉瑞投资有限公司 Pfizer Investment Co Ltd In Review 2020-09-02 view
JXHB2101021 PF-06651600片 ritlecitinib Tablet Chemical Drugs(1) Supplementary Application 2021-06-02 view
JXHB2101093 PF-06651600片 ritlecitinib Tablet Chemical Drugs(1) Supplementary Application 2021-11-11 view
JXHB2200067 PF-06651600片 ritlecitinib Tablet Chemical Drugs(1) Supplementary Application 2022-06-08 view